Palomino Laboratories (PALX) Shares Outstanding (2022 - 2025)

Palomino Laboratories has disclosed Shares Outstanding (Entity) across 4 years of filings, most recently posting $6.7 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 34.22% year-over-year to $6.7 million; the TTM figure through Dec 2025 stood at $6.7 million (up 34.22% YoY), while the FY2025 annual figure was $6.7 million, up 34.22% from the prior year.
• Shares Outstanding (Entity) came in at $6.7 million for Q4 2025 at Palomino Laboratories, up from $3.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $6.7 million in Q4 2025 to a low of $3.4 million in Q3 2025.
• Average Shares Outstanding (Entity) over 4 years is $5.0 million, with a median of $5.0 million recorded in 2022.
• The largest YoY upside for Shares Outstanding (Entity) was 34.22% in 2025 against a maximum downside of 32.32% in 2025.
• Over 4 years, Shares Outstanding (Entity) stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then changed by 0.0% to $5.0 million in 2024, then soared by 34.22% to $6.7 million in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $6.7 million in Q4 2025, $3.4 million in Q3 2025, and $5.0 million in Q2 2025.